This conference is designed for dermatologists, pediatricians, family medicine physicians, internists, OB/GYNs, residents, nurse practitioners, nurses and physician assistants involved in treating diseases of the skin in adult females and pediatric patients.
As a result of participating in this live activity, participants should be better able to: [LIST][ITEM]Examine the efficacy and safety of current and emerging topical therapies. [ITEM]Deliberate on the risks and benefits of systemic therapy in women. [ITEM]Assess and treat acne and rosacea in the adult female patient. [ITEM]Modify patient treatment strategies by considering the full range of current and emerging therapeutic options for atopic dermatitis. [ITEM]Employ treat-to-target strategies with new and emerging therapies for psoriasis. [ITEM]Outline recent advances in the diagnosis and treatment of several severe skin diseases seen in children. [ITEM]Recognize appropriate treatment strategies for treatment of hidradenitis suppurativa. [ITEM]Identify and manage hyperhidrosis. [ITEM]Summarize signs, symptoms, and diagnostic indicators of hidradenitis suppurativa severity levels and describe initial steps for treatment. [ITEM]Detail the diagnosis and management of hemangiomas. [ITEM]Review the factors that increase a patient’s risk for developing actinic keratosis. [ITEM]Discuss the potential of novel treatment options for vitiligo. [ITEM]Integrate strategies for assessing and treating hair disorders in women and children. [ITEM]Detect and manage common dermatologic conditions in skin of color. [ITEM]Evaluate treatment approaches for the adult and pediatric patient with common warts and molluscum contagiosum. [ITEM]Appraise new photoprotective technologies as well as current sunscreen controversies. [ITEM]Analyze the benefits and risks of current agents and techniques commonly used in aesthetic and procedural dermatology. [ITEM]Define the appropriate use and dosing of individual neurotoxin formulations in facial rejuvenation. [ITEM]Select dermal filler agents suitable for use in treating different facial areas. [ITEM]Collaborate across professions to enhance the diagnosis and management of dermatologic conditions.[/LIST]
[JALOGO][PIM] [bold]Joint Accreditation Statement[/bold] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [bold]Physician Continuing Medical Education[/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 11.5 [italic]AMA PRA Category 1 Credits™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education[/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 11.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates. [bold][italic]California Board of Registered Nursing[/bold][/italic] Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 11.5 contact hours. [ABIMMOC] [bold]American Board of Internal Medicine MOC[/bold] Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. [ABOPMOC] [bold]American Board of Pediatrics MOC [/bold] Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.5 MOC points in the American Board of Pediatric’ s (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit. [bold]American Board of Dermatology MOC-D [/bold] The self-assessment program offered at the 17th Annual Women’s & Pediatric Dermatology Seminar is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points. [AAFP] [bold]AAFP Credit [/bold] The AAFP has reviewed the 17th Annual Women’s and Pediatrics Dermatology Seminar and deemed it acceptable for up to 11.50 Live AAFP Prescribed credits. Term of Approval is from 06/03/2022 to 06/04/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [ICPE] [bold]Interprofessional Continuing Education [/bold] This activity was planned by and for the healthcare team, and learners will receive 11.5 Interprofessional Continuing Education (IPCE) credit for learning and change.